New Enterprise Associates 14, L.P. 13D and 13G filings for Adaptimmune Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-19 6:53 pm Sale | 2025-08-15 | 13D | Adaptimmune Therapeutics plc ADAPY | New Enterprise Associates 14, L.P. | 4 0.000% | -102,478,668 (-100.00%) | Filing |
| 2024-04-02 8:38 pm Unchanged | 2024-04-01 | 13D | Adaptimmune Therapeutics plc ADAPY | New Enterprise Associates 14, L.P. | 102,478,672 6.700% | 0 (Unchanged) | Filing |
| 2023-03-30 5:13 pm Purchase | 2023-03-05 | 13D | Adaptimmune Therapeutics plc ADAPY | New Enterprise Associates 14, L.P. | 102,478,672 10.300% | 3,556,804 (+3.60%) | Filing |